Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REGENXBIO Inc. (RGNX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 48.4% | 11.0% | 23.1% | 23.4% | 5.5% | 162.8% | 20.9% | 19.8% |
| Gross profit | 51.6% | 89.0% | 76.9% | 76.6% | 94.5% | -62.8% | 79.1% | 80.2% |
| Selling, general and administrative | 284.8% | 55.0% | 154.0% | | | | | |
| Research and development | | | | 352.5% | 47.6% | 5449.9% | 991.1% | 227.7% |
| General and administrative | | | | 147.1% | 20.9% | 2593.2% | 514.1% | 157.0% |
| EBITDA | -236.8% | 32.1% | -63.0% | -402.6% | 52.3% | -6971.3% | -1412.0% | -303.9% |
| Depreciation | 11.5% | 2.0% | 5.4% | 20.3% | 2.3% | 255.8% | 11.9% | 1.1% |
| EBIT | -248.2% | 30.0% | -68.5% | -422.9% | 50.0% | -7227.1% | -1423.8% | -304.9% |
| Pre-tax income | -248.8% | 30.0% | -68.6% | -276.7% | 59.1% | -6968.5% | -1381.6% | -300.6% |
| Income taxes | -0.1% | 2.9% | 3.4% | -7.8% | 2.4% | 0.0% | -9.5% | 0.0% |
| Net income | -248.7% | 27.2% | -72.0% | -268.9% | 56.8% | -6968.5% | -1372.1% | -313.6% |
|